Rockwell Medical, Inc. Financial Ratios — RMTI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-87.92	- -	- -	-61.55	-22.01	-34.36	-60.37	-106.75	-143.4	-113.38	-178.04	-224.49	-47.68	-1.78	-15.28
Return on Assets (%)	-62.24	-220.66	-182.75	-31.75	-15.52	-23.16	-36.53	-57.71	-70.46	-50.61	-51.73	-39.24	-17.08	-0.86	-9.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	11.52	13.43	12.71	15.77	16.15	12.67	6.46	-2.5	4.63	4.38	-3.91	5.6	10.41	17.23	16.89
EBITDA Margin (%)	-41.88	-106.69	-87.92	-30.57	-25.8	-36.5	-44.34	-48.52	-51.29	-42.01	-44.92	-22.26	-6.25	2.75	-3.61
Operating Margin (%)	-44.29	-108.87	-89.84	-32.4	-27.28	-37.93	-45.24	-49.55	-55.62	-45.69	-48.98	-23.05	-7.98	0.6	-6.77
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	40.71	- -
Pretax Margin (%)	-43.79	-108.38	-93.13	-39.36	-26.05	-36.41	-45.24	-50.68	-55.67	-49.66	-52.76	-25.65	-10.09	-0.47	-7.67
Profit Margin (%)	-43.79	-108.38	-93.13	-39.36	-26.05	-37.16	-45.24	-50.68	-55.67	-49.66	-52.76	-25.65	-10.09	-0.47	-7.67
Net Income to Common Margin (%)	-43.79	-108.38	-93.13	-39.36	-26.05	-37.16	-45.24	-50.68	-55.67	-49.66	-52.76	-25.65	-10.09	-0.47	-7.67
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-87.92	- -	- -	-61.55	-22.01	-34.36	-60.37	-106.75	-143.4	-113.38	-178.04	-224.49	-47.68	-1.78	-15.28

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	20	- -	- -	- -	- -	- -	4	24	29	16	13	14	12
ST Debt	- -	- -	2	- -	- -	- -	- -	- -	2	1	10	4	2	2	2
LT Debt	- -	- -	18	- -	- -	- -	- -	- -	2	23	19	12	11	11	11
Total Debt/EBITDA	- -	- -	-0.44	- -	- -	- -	- -	- -	-0.13	-0.92	-1.04	-1.01	-2.57	4.85	-4.99
Net Debt/EBITDA	0.28	0.09	-0.18	3.97	2.18	0.88	0.33	0.74	0.35	1.06	-0.28	0.03	0.09	-2.48	0.65
Total Debt/EBIT	- -	- -	-0.43	- -	- -	- -	- -	- -	-0.12	-0.84	-0.95	-0.98	-2.01	22.26	-2.66
Net Debt/EBIT	0.26	0.09	-0.18	3.75	2.07	0.85	0.32	0.72	0.32	0.98	-0.25	0.02	0.07	-11.38	0.35
EBITDA to Interest Expense	-11,121.88	-55,914.5	-25.27	-3.99	- -	- -	- -	- -	-1,257.68	-13.91	-11.79	-8.37	-2.27	2.22	-2.22
EBITDA-CapEx/Interest Expense	-11,428.91	-56,448.45	-25.63	-4.15	- -	- -	- -	- -	-1,311.2	-14.46	-12.01	-8.51	-2.39	1.42	-2.71
EBIT to Interest Expense	-11,759.63	-57,057.92	-25.83	-4.23	- -	- -	- -	- -	-1,363.8	-15.13	-12.85	-8.67	-2.9	0.48	-4.17
Interest Expense	- -	- -	2	4	- -	- -	- -	- -	- -	2	2	2	2	1	1
Common Equity/Total Assets	57.12	-58.51	1.64	70.11	70.96	63.68	55.99	51.9	45.85	43.95	5.22	30.25	40.81	55.04	64.71
Long-Term Debt/Equity (%)	0.01	- -	3,008.52	- -	- -	- -	- -	- -	8.76	66.64	752.39	86.66	52.87	34.07	28.62
Long-Term Debt/Capital (%)	0.01	- -	86.05	- -	- -	- -	- -	- -	7.31	39.19	60.68	40.12	32.41	24.07	21.4
Long-Term Debt/Total Assets (%)	0.01	- -	49.27	- -	- -	- -	- -	- -	4.02	29.29	39.27	26.21	21.57	18.75	18.52
Total Debt/Equity (%)	0.05	-0.02	3,396.09	- -	- -	- -	- -	- -	19.87	70.05	1,139.84	116	63.12	41.54	33.73
Total Debt/Capital (%)	0.05	-0.02	97.14	- -	- -	- -	- -	- -	16.57	41.19	91.93	53.7	38.7	29.35	25.22
Total Debt/Total Assets (%)	0.03	0.01	55.62	- -	- -	- -	- -	- -	9.11	30.79	59.49	35.09	25.76	22.86	21.83
Net Debt to Equity	-31.33	47.3	1,401.02	-95.78	-50.06	-32.44	-25.54	-83.27	-54.29	-81.16	304.69	-2.93	-2.09	-21.24	-4.38
Net Debt/Capital (%)	-45.58	32.12	93.34	-2,267.15	-100.25	-48.02	-34.31	-497.8	-87.82	-294.25	42.56	-2.03	-1.73	-22.73	-4.18
EBITDA	-21	-53	-46	-17	-14	-19	-25	-31	-31	-26	-28	-16	-5	3	-2
EBITDA-CapEx	-21	-54	-47	-17	-15	-20	-27	-32	-33	-27	-28	-16	-6	2	-3
Operating Income (Loss)	-22	-54	-47	-18	-15	-20	-26	-31	-34	-28	-30	-17	-7	1	-5

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.28	0.17	1.34	8.74	8.74	5.71	3.62	2.54	2.1	4.59	1.07	1.21	0.66	1.53	2.61
Current Ratio	1.89	0.49	1.79	9.66	10.46	7.74	5.34	3.55	2.98	5.43	1.68	2	1.73	2.63	3.98
Quick Ratio	1.59	0.34	1.6	9.2	9.36	6.34	4.31	3.1	2.44	4.91	1.35	1.57	1.31	2.12	3.46
CFO/Avg Current Liab	-1.07	-1.51	-2.26	0.31	-1.49	-1.37	-2.19	-1.83	-2.13	-2.36	-1.99	-0.88	-0.55	0.27	-0.06
Common Equity/Total Assets	57.12	-58.51	1.64	70.11	70.96	63.68	55.99	51.9	45.85	43.95	5.22	30.25	40.81	55.04	64.71
Long-Term Debt/Equity (%)	0.01	- -	3,008.52	- -	- -	- -	- -	- -	8.76	66.64	752.39	86.66	52.87	34.07	28.62
Long-Term Debt/Capital (%)	0.01	- -	86.05	- -	- -	- -	- -	- -	7.31	39.19	60.68	40.12	32.41	24.07	21.4
Long-Term Debt/Total Assets (%)	0.01	- -	49.27	- -	- -	- -	- -	- -	4.02	29.29	39.27	26.21	21.57	18.75	18.52
Total Debt/Equity (%)	0.05	-0.02	3,396.09	- -	- -	- -	- -	- -	19.87	70.05	1,139.84	116	63.12	41.54	33.73
Total Debt/Capital (%)	0.05	-0.02	97.14	- -	- -	- -	- -	- -	16.57	41.19	91.93	53.7	38.7	29.35	25.22
Total Debt/Total Assets (%)	0.03	0.01	55.62	- -	- -	- -	- -	- -	9.11	30.79	59.49	35.09	25.76	22.86	21.83
CFO/Total Liabilities	-78.74	-113.93	-141.65	14.53	-52.26	-41.24	-81.62	-80.77	-113.57	-68.02	-72.84	-52.04	-30.48	15.78	-3.27
CFO/CapEx	-19.05	-60.55	-77.45	6.22	-16.35	-35.05	-12.55	-20.54	-20.37	-28.34	-64.24	-60.25	-33.14	4.16	-1.22
Altman's Z-Score	4.08	-15.58	-1.8	8.99	10.39	3.89	1.51	-4.32	-6.4	-4.37	-10.81	-10.84	-10.78	-7.29	-9.25

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	11.22	11.52	11.63	11.97	11.63	9.32	8.99	9.51	10.96	14.85	12.28	11.96	9.74	10.58	8.43
Days Sales Outstanding	32.54	31.69	31.39	30.48	31.38	39.18	40.6	38.39	33.29	24.57	29.72	30.51	37.46	34.51	43.3
Inventory Turnover	15.92	16.74	16.78	13.58	7.87	4.65	5.42	11.13	15.21	15.73	16.11	13.9	12.82	14.42	12.51
Days Inventory Outstanding	22.92	21.8	21.75	26.87	46.37	78.49	67.34	32.8	23.99	23.2	22.66	26.26	28.47	25.31	29.17
Accounts Payable Turnover	9.51	4.29	3.9	6.69	10.84	10.31	9.74	14.09	15.47	16.66	16.35	18.09	17.5	22.72	22.68
Accounts Payable Turnover Days	38.4	85.14	93.58	54.56	33.66	35.4	37.47	25.91	23.6	21.91	22.33	20.18	20.86	16.06	16.09
Cash Conversion Cycle	17.06	-31.65	-40.43	2.79	44.09	82.28	70.48	45.28	33.68	25.86	30.04	36.59	45.06	43.76	56.39
Inventory to Cash Days	9.62	9.89	9.64	3.61	-14.98	-39.31	-26.74	5.6	9.3	1.37	7.06	4.25	8.99	9.2	14.13
Inventories	3	3	3	4	8	12	8	4	4	4	4	6	6	6	3
Raw Materials	1	1	1	2	6	11	11	- -	- -	- -	- -	3	2	3	2
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	2	1	1	2	2	3	3	- -	- -	- -	- -	2	3	2	1
Other Inventory	- -	- -	- -	- -	- -	-2	-6	4	4	4	4	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	158	173	419	517	527	338	301	129	160	95	39	12	55	69	33
- Cash & Cash Equivalents	6	5	12	66	31	17	8	23	12	49	13	10	9	16	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	20	- -	- -	- -	- -	- -	4	24	29	16	13	14	12
Enterprise Value	141	168	415	431	457	280	268	95	138	60	45	7	58	61	20
Total Capital	18	-10	21	69	62	53	33	27	24	58	31	30	35	46	49
Total Debt/Capital (%)	0.05	-0.02	97.14	- -	- -	- -	- -	- -	16.57	41.19	91.93	53.7	38.7	29.35	25.22
Total Debt / EV	- -	- -	0.05	- -	- -	- -	- -	- -	0.03	0.4	0.64	2.29	0.23	0.22	0.61
EV/Sales	2.88	3.38	7.92	7.96	8.25	5.25	4.68	1.5	2.24	0.96	0.73	0.1	0.69	0.61	0.29
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.03	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	101	- -
EV/Cash Flow to Firm	- -	- -	- -	51.26	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.26	43.74
EV/Free Cash Flow to Firm	- -	- -	- -	47.4	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.5	20.2
Diluted Market Cap	150	164	344	426	509	333	296	119	149	76	38	10	44	63	30
Diluted Enterprise Value	144	159	352	360	478	315	287	97	141	52	54	16	49	61	32
EV per Share	828.71	861.4	1,138.28	943.26	975.44	596.81	569.96	183.93	231.37	70.26	52.66	5.88	19.76	18.03	5.16
TTM Sales	49	50	52	54	55	53	57	63	61	62	62	73	84	101	69
TTM EBITDA	-21	-53	-46	-17	-14	-19	-25	-31	-31	-26	-28	-16	-5	3	-2
TTM Operating Income	-22	-54	-47	-18	-15	-20	-26	-31	-34	-28	-30	-17	-7	1	-5
TTM Cash Flow to Firm	-11	-31	-49	8	-13	-12	-21	-20	-27	-28	-31	-15	-7	5	- -
TTM Free Cash Flow to Firm	-10	-30	-48	9	-13	-12	-19	-19	-26	-27	-31	-15	-7	6	1

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-14.69	-5.43	-6.88	86.12	-40.69	-27.49	-15.22	-6.15	-5.74	-2.67	-1.16	-0.6	-4.83	12.15	-256.43
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	101	- -
Enterprise Value	141	168	415	431	457	280	268	95	138	60	45	7	58	61	20
Low Price	748	569.8	347.6	891	779.9	390.5	556.6	240.9	199.1	91.3	37.4	8.4	10	11.6	7.8
EV/Sales	2.88	3.38	7.92	7.96	8.25	5.25	4.68	1.5	2.24	0.96	0.73	0.1	0.69	0.61	0.29
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.03	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-8.05	-3.27	-4.77	-20.52	-39.65	-18.76	-13.14	-7.9	-6.15	-4.47	-2.46	-1.24	-6.71	-142.31	-8.53
Price/Earnings High	-13.98	-4.44	-10.71	-28.73	-65.17	-27.13	-17.61	-11.38	-12.28	-9.43	-5.68	-3.78	-17.25	-333.23	-16.31
Price/Earnings Low	-5.62	-1.96	-2.14	-15.73	-24.45	-9.1	-9.92	-3.6	-3.23	-2.03	-0.98	-0.44	-2.76	-75.06	-5.28
Price/Book Value	8.69	-17.37	703.15	7.52	8.46	6.37	9.15	4.73	7.85	2.77	15.2	0.87	2.59	2.13	0.89
Price/Book Value Average	9.99	-18.69	475.33	7.74	9.5	7.12	10.54	10.04	11.09	5	31.83	2.03	3.32	2.3	1.34
Price/Book Value High	17.34	-25.35	1,067.53	10.83	15.62	10.29	14.12	14.47	22.14	10.54	73.41	6.17	8.54	5.38	2.57
Price/Book Value Low	6.97	-11.18	212.83	5.93	5.86	3.45	7.96	4.58	5.82	2.27	12.61	0.72	1.37	1.21	0.83
Price/Tangible Book Value	9.61	-14.98	-507.63	7.66	8.61	6.49	9.42	4.89	8.22	2.84	23.88	0.93	5.73	3.24	1.24
Price/Tangible Book Value Average	11.06	-16.12	-343.16	7.88	9.67	7.24	10.85	10.39	11.62	5.14	50	2.17	7.36	3.49	1.88
Price/Tangible Book Value High	19.19	-21.87	-770.68	11.03	15.9	10.48	14.53	14.97	23.19	10.84	115.3	6.6	18.91	8.17	3.6
Price/Tangible Book Value Low	7.72	-9.64	-153.65	6.04	5.96	3.52	8.19	4.74	6.1	2.34	19.8	0.77	3.03	1.84	1.16
Price/Sales	3.07	3.29	6.57	7.85	9.2	6.24	5.16	1.88	2.42	1.23	0.62	0.14	0.53	0.62	0.43
Price/Sales Average	3.53	3.54	4.44	8.08	10.33	6.97	5.94	4	3.43	2.22	1.3	0.32	0.68	0.67	0.65
Price/Sales High	6.12	4.81	9.97	11.31	16.98	10.08	7.97	5.77	6.84	4.68	3	0.97	1.74	1.58	1.25
Price/Sales Low	2.46	2.12	1.99	6.19	6.37	3.38	4.49	1.83	1.8	1.01	0.51	0.11	0.28	0.35	0.41
Price/Cash Flow	-13.92	-5.34	-6.79	99.97	-38.2	-26.71	-14.01	-5.85	-5.45	-2.58	-1.15	-0.59	-4.68	15.08	-45.53
Price/Cash Flow Average	-16.02	-5.75	-4.59	102.81	-42.9	-29.83	-16.13	-12.42	-7.71	-4.66	-2.4	-1.37	-6.02	16.26	-68.77
Price/Cash Flow High	-27.79	-7.79	-10.31	143.92	-70.51	-43.14	-21.62	-17.9	-15.38	-9.82	-5.54	-4.17	-15.46	38.07	-131.56
Price/Cash Flow Low	-11.18	-3.44	-2.06	78.77	-26.45	-14.48	-12.18	-5.67	-4.05	-2.12	-0.95	-0.49	-2.48	8.57	-42.58
Price/Free Cash Flow Average	-16.9	-5.84	-4.65	88.57	-45.7	-30.71	-17.53	-13.06	-8.11	-4.83	-2.44	-1.4	-6.21	13.1	-387.32
Price/Free Cash Flow High	-29.33	-7.93	-10.45	123.99	-75.11	-44.41	-23.49	-18.82	-16.17	-10.18	-5.63	-4.24	-15.94	30.68	-741.01
Price/Free Cash Flow Low	-11.8	-3.49	-2.08	67.86	-28.18	-14.9	-13.24	-5.96	-4.25	-2.19	-0.97	-0.5	-2.56	6.91	-239.83
EV/Sales Average	3.61	3.64	5.56	8.6	10.14	6.75	5.91	3.96	3.55	2.35	1.56	0.48	0.9	0.72	0.74
EV/Sales High	6.34	4.97	12.3	12.52	17.02	9.91	7.97	5.87	7.21	5.39	3.26	1.28	2.23	1.71	1.4
EV/Sales Low	2.48	2.14	2.58	6.3	6.03	3.11	4.42	1.61	1.8	0.85	0.77	0.23	0.4	0.37	0.47
EV/EBITDA Average	-8.61	-3.41	-6.33	-28.12	-39.29	-18.5	-13.32	-8.16	-6.92	-5.59	-3.46	-2.16	-14.39	26.1	-20.57
EV/EBITDA High	-15.15	-4.66	-13.99	-40.96	-65.98	-27.15	-17.97	-12.09	-14.06	-12.84	-7.25	-5.75	-35.64	62.15	-38.71
EV/EBITDA Low	-5.93	-2.01	-2.93	-20.62	-23.39	-8.52	-9.98	-3.32	-3.52	-2.03	-1.71	-1.02	-6.43	13.41	-13
EV/EBIT Average	-8.15	-3.34	-6.19	-26.53	-37.15	-17.8	-13.06	-8	-6.38	-5.14	-3.17	-2.08	-11.27	119.7	-10.96
EV/EBIT High	-14.33	-4.57	-13.69	-38.64	-62.39	-26.13	-17.61	-11.84	-12.97	-11.81	-6.65	-5.56	-27.92	284.98	-20.62
EV/EBIT Low	-5.6	-1.97	-2.87	-19.45	-22.11	-8.2	-9.78	-3.25	-3.24	-1.86	-1.57	-0.98	-5.04	61.48	-6.93
Last Price	931.7	885.5	1,148.4	1,130.8	1,126.4	720.5	640.2	248.6	268.4	111.1	45.1	10.1	18.9	20.4	8.34
High Price	1,860.1	1,292.5	1,743.5	1,628	2,079	1,163.8	987.8	761.2	756.8	423.5	217.8	71.5	62.4	51.5	24.1
Enterprise Value Average	177	181	291	466	561	360	339	251	218	146	96	35	75	73	51
Enterprise Value High	311	248	644	678	942	528	456	372	442	336	202	93	186	173	97
Enterprise Value Low	122	107	135	341	334	166	254	102	111	53	48	16	34	37	32

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	3	3	4
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	2	3	4
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	2	3	4
Revenue per Share	303.92	268.81	174.8	143.96	122.44	115.43	124.01	132	110.69	90.47	72.64	73.79	35.85	32.68	19.25
EBITDA per Share	-127.29	-286.78	-153.68	-44	-31.59	-42.13	-54.99	-64.05	-56.77	-38.01	-32.63	-16.42	-2.24	0.9	-0.69
Operating Income per Share	-134.59	-292.65	-157.05	-46.65	-33.41	-43.78	-56.1	-65.41	-61.57	-41.34	-35.58	-17.01	-2.86	0.2	-1.3
Basic EPS, GAAP	-133.1	-291.35	-162.8	-56.66	-31.9	-42.9	-56.1	-66.9	-61.62	-44.93	-38.32	-18.93	-3.62	-0.15	-1.48
Basic EPS from Cont Ops	-133.1	-291.35	-162.8	-56.66	-31.9	-42.9	-56.1	-66.9	-61.62	-44.93	-38.32	-18.93	-3.62	-0.15	-1.48
Diluted EPS, GAAP	-133.1	-291.35	-162.8	-56.66	-31.9	-42.9	-56.1	-66.9	-61.62	-44.93	-38.32	-18.93	-3.62	-0.15	-1.48
Diluted EPS from Cont Ops	-133.1	-291.35	-162.8	-56.66	-31.9	-42.9	-56.1	-66.9	-61.62	-44.93	-38.32	-18.93	-3.62	-0.15	-1.48
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-66.93	-165.83	-169.08	11.31	-29.48	-26.98	-45.69	-42.52	-49.21	-43.12	-39.33	-17.16	-4.04	1.35	-0.18
Free Cash Flow per Basic Share	-70.44	-168.56	-171.26	9.49	-31.29	-27.75	-49.34	-44.59	-51.63	-44.64	-39.94	-17.44	-4.16	1.03	-0.33
Cash & Equivalents per Share	103.04	24.11	65.59	187.54	150.96	123.69	70.24	64.67	43.82	68.98	26.26	17.67	3.75	6.34	6.34
Book Value per Share	107.27	-50.98	1.63	150.29	133.11	113.05	69.94	52.61	34.19	40.17	2.97	11.6	7.31	9.57	9.38
Tangible Book Value per Share	96.95	-59.1	-2.26	147.55	130.79	111.07	67.98	50.83	32.64	39.09	1.89	10.84	3.3	6.3	6.7

Rockwell Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)